Thyroid disease

The Effects of Patient Characteristics on the Management of Subclinical Hypothyroidism: A Survey of Faculty and Trainees

Endocr PractPublished Cross-sectional study

Authors' conclusion

The presence of symptoms, thyroid stimulating hormone >10 mIU/L, and desire for fertility were most predictive of the decision to treat in SCH. In several clinical scenarios, both trainee and faculty decision-making demonstrated discordance with general SCH management principles.

Study context

Population
Faculty members and medical trainees at multiple academic medical centers; 9 clinical scenarios of women with subclinical hypothyroidism (SCH), 5 management options from most conservative to most aggressive (levothyroxine)
Participants
194 survey respondents
Exposure
Faculty members vs trainees
  • Facultyn = 95
  • Traineesn = 99reference
Outcome
Impact of patient characteristics on SCH management decisions (predicted probability of treatment)
Methodological detailsonline survey, multicentre, clinical scenarios
  • Online survey
  • Multicentre
  • Clinical scenarios

Main finding

As reported in the abstract

Clinical factors with highest predicted probability of treatment (all respondents)

Hypothyroid symptoms: PP 68.8%, 95% CI

65.7%-71.9%

TSH >10 mIU/L in a 31-year-old: PP 63.9%, 95% CI

60.3%-67.3%

Desire for fertility: PP 52.2%, 95% CI

48.6%-56.0%

Observational data: associations, not effects.

Further findings

Confident or very confident in diagnosing SCH

P < 0.001

Consider patient preference for treatment

P < 0.001

Treatment aggressiveness across scenarios

Faculty favored more aggressive treatment across all clinical scenarios

Original publication

The Effects of Patient Characteristics on the Management of Subclinical Hypothyroidism: A Survey of Faculty and Trainees. Endocr Pract. Published 6 August 2023. doi:10.1016/j.eprac.2023.07.031

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.